Myriad Genetics Inc
XETRA:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XETRA:MYD
|
US |
|
C
|
Cheerwin Group Ltd
HKEX:6601
|
CN |
|
S
|
Sky Gold Ltd
NSE:SKYGOLD
|
IN |
|
Learning Technologies Group PLC
LSE:LTG
|
UK |
|
Highgold Mining Inc
XTSX:HIGH
|
CA |
|
D
|
Demant A/S
SWB:WDH1
|
DK |
|
EMCOR Group Inc
NYSE:EME
|
US |
|
K
|
KME Group SpA
MIL:KME
|
IT |
|
MIT Holdings Co Ltd
TSE:4016
|
JP |
|
Zhejiang Dafeng Industrial Co Ltd
SSE:603081
|
CN |
|
Power Assets Holdings Ltd
HKEX:6
|
HK |
|
A
|
Articore Group Ltd
ASX:ATG
|
AU |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
444.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 119.9m USD. This includes both short-term (0 USD) and long-term (119.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
